Safety Alert for ADVIA CHEMISTRY LIPASE REAGENTS (LIP) - Record 10345160626 - Model Kit of 4 x 160 tests: Reagent 1 (4 x 18 ml) / Reagent 2 (4 x 10 ml) - Lots 332463; 318706 (SCHEDULE OF DISTRIBUTION IN ANNEX)

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by SIEMENS HEALTHCARE DIAGNÓSTICOS S.A; SIEMENS HEALTHCARE DIAGNOSTICS, INC..

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1556
  • Date
    2015-04-24
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    Company recommends: "* If the lipid panel (Triglycerides, Triglycerides, Triglycerides Concentrate, Cholesterol Concentrate and LDL Direct Cholesterol) is not being used together with the determination of Lipase in ADVIA Chemistry Systems, no action is required. * If the lipid panel is used in conjunction with Lipase in the ADVIA Chemistry Systems, Siemens recommends the following protocol to minimize the potential for falsely elevated Lipase assay results. a) Customers with two or more ADVIA Chemistry Systems shall perform the defined tests on the Lipid and Lipase panel in ADVIA Chemistry Systems separately. b) Clients with a single ADVIA Chemistry System and laboratories that choose to maintain lipase in the same system with the lipid panel should perform the automatic replication protocol described in the Letter to Customer to mitigate the possibility of obtaining falsely elevated Lipase test results. ".
  • Reason
    Siemens healthcare diagnostics has identified a high bias potential for the lipase assay in advia chemistry systems due to carryover of one or more of the following tests: triglycerides, triglycerides 2, triglycerides concentrate, cholesterol concentrate and ldl cholesterol direct. the potential carryover by these reagents can be mitigated from the design of designated contamination avoidance protocols. however, under certain circumstances, rare carryover incidents may occur.
  • Action
    The company is contacting its clients and providing guidance on the procedures to be followed (ANNEX) CHC Code 15-07

Manufacturer